Shopping Cart
- Remove All
- Your shopping cart is currently empty
Orforglipron (LY3502970; GLP-1 receptor agonist 1) is an orally available glucagon-like peptide (GLP-1) receptor agonist for the study of obesity and type 1 diabetes in adults.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $256 | In Stock | |
5 mg | $628 | In Stock | |
10 mg | $987 | In Stock | |
25 mg | $1,980 | In Stock | |
50 mg | $2,730 | In Stock | |
100 mg | $3,690 | In Stock | |
1 mL x 10 mM (in DMSO) | $39 | In Stock |
Description | Orforglipron (LY3502970; GLP-1 receptor agonist 1) is an orally available glucagon-like peptide (GLP-1) receptor agonist for the study of obesity and type 1 diabetes in adults. |
In vitro | Orforglipron potently stimulates GLP-1R-induced cAMP accumulation with partial agonist activity and no detectable recruitment of GLP-1R-mediated β-arrestin was observed[2]. |
Alias | LY3502970, GLP-1 receptor agonist 1 |
Molecular Weight | 882.96 |
Formula | C48H48F2N10O5 |
Cas No. | 2212020-52-3 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 44.15 mg/mL (50 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.